MRNA vs SPSC · rev $145.0M vs P/E 22, rev $389.9M
Moderna Inc (MRNA) versus SPS Commerce Inc (SPSC) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
SPS Commerce Inc (SPSC) is a software - application company listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported SPSC revenue for 2026-06-30 was $389.9M. Net income was $26.6M. SPSC currently screens at market cap $1.94B and trailing P/E 21.9.
MRNA currently screens at market cap $24.52B. SPSC currently screens at market cap $1.94B and trailing P/E 21.9.
Not investment advice. Open the MRNA and SPSC stock pages for the full models.
Not investment advice.